FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162267314> ?p ?o ?g. }

• W2162267314 endingPage "246" @default.
• W2162267314 startingPage "234" @default.
• W2162267314 abstract "OKT3 is the first anti-CD3 monoclonal antibody available for treatment in humans. Over the last few years it has proven to be a very powerful immunosuppressive agent in renal transplantation. Clinical studies have shown that OKT3 is superior to high-dose steroids as first-line treatment for acute renal allograft rejection. Furthermore, it is comparable to antithymocyte globulin (ATG) in treating steroid-resistant rejection and is also effective as rescue treatment in ATG- and antilymphocyte globulin-(ALG-) resistant rejection. Despite its excellent rejection-reversal rate, OKT3 treatment is followed by a substantial percentage of re-rejections, most of which respond well to steroids. In the early post-transplantation period, a prophylactic course of OKT3 is very effective in preventing acute rejections, and in this respect it is probably equivalent to ATG. Indirect evidence exists that a prophylactic course of OKT3 may be beneficial in immunologically high-risk patients and in patients with delayed graft function. However, more clinical studies are required to answer the question whether OKT3 should be given as induction treatment, as first-line treatment, or as rescue treatment. To answer this question, the side effects of OKT3 should also be taken into account. First-dose-related side effects, although frequent and disturbing, are usually transient and seldom life-threatening, provided overhydration has been corrected and steroids have been given before the first administration. These side effects are attributed to the release of cytokines as a result of T-cell activation or lysis. After exposure of patients to OKT3 an increased incidence of infections and malignancies has been reported. However, it is not yet clear whether this is due to OKT3 as such, or whether it merely reflects the total burden of immunosuppression. Xeno-sensitization represents an important limitation to OKT3 treatment, although a second or third course can still be effective in patients with low antibody titers. The precise immunosuppressive mechanism of anti-CD3 monoclonal antibodies is yet unknown. Monitoring of patients treated with OKT3 revealed CD3 and/or T-cell antigen receptor depletion and immunological incompetence of remaining T cells. More clinical data are required to establish the correct dose and duration of OKT3 treatment. In conclusion, OKT3 is a powerful immunosuppressive agent but its real value in renal transplantation remains to be determined. A practical approach may be to reserve it for the treatment of steroid-resistant rejections.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2162267314 created "2016-06-24" @default.
• W2162267314 creator A5029096064 @default.
• W2162267314 creator A5049740893 @default.
• W2162267314 date "1992-09-01" @default.
• W2162267314 modified "2023-09-23" @default.
• W2162267314 title "Monoclonal antibodies in renal transplantation: a review" @default.
• W2162267314 cites W147473274 @default.
• W2162267314 cites W1966729095 @default.
• W2162267314 cites W1968713831 @default.
• W2162267314 cites W1970166758 @default.
• W2162267314 cites W1976375827 @default.
• W2162267314 cites W1976429918 @default.
• W2162267314 cites W1976772218 @default.
• W2162267314 cites W1980793481 @default.
• W2162267314 cites W1983357778 @default.
• W2162267314 cites W1986010227 @default.
• W2162267314 cites W1990259641 @default.
• W2162267314 cites W1990529390 @default.
• W2162267314 cites W1991942320 @default.
• W2162267314 cites W1994604086 @default.
• W2162267314 cites W1995253183 @default.
• W2162267314 cites W1996431651 @default.
• W2162267314 cites W1997068340 @default.
• W2162267314 cites W1999121976 @default.
• W2162267314 cites W2001782250 @default.
• W2162267314 cites W2002377882 @default.
• W2162267314 cites W2004469794 @default.
• W2162267314 cites W2007609295 @default.
• W2162267314 cites W2010116988 @default.
• W2162267314 cites W2011291552 @default.
• W2162267314 cites W2011366727 @default.
• W2162267314 cites W2012378066 @default.
• W2162267314 cites W2014861510 @default.
• W2162267314 cites W2016206569 @default.
• W2162267314 cites W2017714449 @default.
• W2162267314 cites W2019767935 @default.
• W2162267314 cites W2021042088 @default.
• W2162267314 cites W2027443462 @default.
• W2162267314 cites W2027513535 @default.
• W2162267314 cites W2027922729 @default.
• W2162267314 cites W2030191795 @default.
• W2162267314 cites W2030522563 @default.
• W2162267314 cites W2030551319 @default.
• W2162267314 cites W2031812880 @default.
• W2162267314 cites W2035686694 @default.
• W2162267314 cites W2035938515 @default.
• W2162267314 cites W2039049552 @default.
• W2162267314 cites W2039209624 @default.
• W2162267314 cites W2040720879 @default.
• W2162267314 cites W2041901781 @default.
• W2162267314 cites W2042336731 @default.
• W2162267314 cites W2043279768 @default.
• W2162267314 cites W2045490787 @default.
• W2162267314 cites W2045902680 @default.
• W2162267314 cites W2047859678 @default.
• W2162267314 cites W2048029065 @default.
• W2162267314 cites W2052060671 @default.
• W2162267314 cites W2052154101 @default.
• W2162267314 cites W2058834692 @default.
• W2162267314 cites W2060209521 @default.
• W2162267314 cites W2060516601 @default.
• W2162267314 cites W2060901966 @default.
• W2162267314 cites W2070714215 @default.
• W2162267314 cites W2071232194 @default.
• W2162267314 cites W2071647302 @default.
• W2162267314 cites W2073302853 @default.
• W2162267314 cites W2073754816 @default.
• W2162267314 cites W2074011660 @default.
• W2162267314 cites W2074125587 @default.
• W2162267314 cites W2076632597 @default.
• W2162267314 cites W2077228061 @default.
• W2162267314 cites W2078095249 @default.
• W2162267314 cites W2083750559 @default.
• W2162267314 cites W2086133903 @default.
• W2162267314 cites W2089435636 @default.
• W2162267314 cites W2103964288 @default.
• W2162267314 cites W2108391599 @default.
• W2162267314 cites W2147142199 @default.
• W2162267314 cites W2152086352 @default.
• W2162267314 cites W2160434651 @default.
• W2162267314 cites W2322553446 @default.
• W2162267314 cites W2332022311 @default.
• W2162267314 cites W2332754031 @default.
• W2162267314 cites W2341259055 @default.
• W2162267314 cites W2413704148 @default.
• W2162267314 cites W2443547852 @default.
• W2162267314 cites W4211098439 @default.
• W2162267314 cites W4229505740 @default.
• W2162267314 cites W4233298376 @default.
• W2162267314 cites W4239919719 @default.
• W2162267314 cites W4242404752 @default.
• W2162267314 cites W4242564610 @default.
• W2162267314 doi "https://doi.org/10.1007/bf00336077" @default.
• W2162267314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1418316" @default.
• W2162267314 hasPublicationYear "1992" @default.
• W2162267314 type Work @default.
• W2162267314 sameAs 2162267314 @default.

• next